IGF1 and thromboangiitis obliterans: Our results also show that treatment with IGF-1 induced proliferation (Fig 1A) and HA secretion (Fig 3), and the phosphorylation of IGF-1Rβ at Tyr1135, Akt at Thr308, and Ser473, and ERK (Fig 4) in OFs from TAO patients.